Poltreg S.A. (WSE:PTG)
Poland · Delayed Price · Currency is PLN 22.80
+0.40 (1.79%)
Sep 11, 2026, 2:12 PM CET
Poltreg Market Cap
Poltreg has a market cap or net worth of 134.9 million as of September 11, 2026. Its market cap has increased by 1.14% in one year.
Market Cap
134.90M
Enterprise Value
133.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22.80
ChartMarket Cap Chart
Since November 23, 2021, Poltreg's market cap has decreased from 289.09M to 134.90M, a decrease of -53.34%. That is a compound annual growth rate of -14.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 134.90M | 18.07% |
| Dec 30, 2025 | 114.25M | -33.06% |
| Dec 30, 2024 | 170.68M | -26.51% |
| Dec 29, 2023 | 232.24M | 8.26% |
| Dec 30, 2022 | 214.52M | -39.56% |
| Dec 30, 2021 | 354.90M | 22.77% |
| Nov 23, 2021 | 289.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 549.94M |
| Captor Therapeutics Spolka Akcyjna | 454.90M |
| Bioceltix | 427.64M |
| Ryvu Therapeutics | 406.91M |
| BIOTON | 324.14M |
| Synthaverse | 226.55M |
| Molecure | 140.93M |
| Mabion | 126.23M |